Swiss MedTech Strategic Executive Document
Budget: $15 – $25 USD
Executive Go to Market Document Switzerland
Company: Integra LifeSciences
Portfolio: Codman Surgical
Market: Switzerland
⸻
Objective
I am looking for a professional executive level document to be used in a personal discussion with the Head of Europe at Integra LifeSciences.
The document should demonstrate that I:
• have a realistic understanding of the Swiss MedTech market
• can clearly position the Codman Surgical portfolio
• correctly differentiate between capital equipment and consumables
• have a clear and pragmatic go to market approach for Switzerland
This is not marketing material, not a sales brochure, and not a presentation.
It is a strategic discussion document at executive level.
⸻
Expected Scope
• Target length: 1 to 2 pages executive pitch
• Optional extension: up to a maximum of 5 pages, only if it adds clear value
• The document must not feel overloaded
• Clarity, structure, and readability have priority over length
⸻
Deadline
Express delivery today
⸻
Target Audience
• Head of Europe, Integra LifeSciences
• European executive management
⸻
Delivery Format
Delivery is required as:
• PDF (final version)
• Editable file
• Word (.docx) or Google Docs
⸻
Layout and Style
• Very clean, high quality executive layout
• Calm consulting style
• Clear typography and generous white space
• Structured tables and concise sections
• No design gimmicks or marketing look
• Suitable to be printed and placed on the table during the meeting
Design should support the content, not dominate it.
⸻
Content Guidelines
1. Swiss Market Overview
• Switzerland as a small, highly structured market
• Relatively low annual procedure volumes
• High requirements for quality, evidence, and standardization
• Limited number of clearly defined neuro centers and reference hospitals
Short, factual, and precise.
⸻
2. Codman Surgical Portfolio Overview
Structured overview of the portfolio with clear separation:
Capital Equipment
• Typical products
• Clinical use
• Investment logic in Switzerland
• Typical decision makers
Consumables
• Typical products
• Clinical use
• Recurring consumption
• Purchasing and standardization logic
No marketing language. No superlatives.
⸻
3. Go to Market Approach Switzerland
• Different market approaches for:
• Capital equipment
• Consumables
• Role of:
• Reference hospitals
• Evaluations and pilot projects
• Clinical key opinion leaders
• Impact of low procedure volumes on prioritization and planning
⸻
4. Target Hospitals Switzerland
High level overview:
• University hospitals
• Large cantonal hospitals
• Selected private clinics
No need for a complete hospital list. Focus on logic and structure.
⸻
5. Optional: 90 Day Plan Switzerland
If useful, a concise and structured overview:
• Days 1 to 30: Market, portfolio, stakeholders
• Days 31 to 60: Clinical anchoring, references
• Days 61 to 90: Pilot projects, next steps
Maximum one page.
⸻
6. Closing Insight
Short, composed closing statement:
• Why Codman Surgical should be developed in Switzerland in a controlled and sustainable way
• Why a differentiated approach between capital equipment and consumables is critical
⸻
Tone
• Executive
• Clear
• Calm
• Confident
• No application language
• No sales jargon
⸻
Not Desired
• No marketing claims
• No SWOT analysis
• No assumptions about internal Integra numbers
• No overloaded charts or graphics
⸻
Expected Outcome
A document that makes a European executive think:
“This person understands the Swiss market and already thinks in terms of ownership and responsibility.”
Company: Integra LifeSciences
Portfolio: Codman Surgical
Market: Switzerland
⸻
Objective
I am looking for a professional executive level document to be used in a personal discussion with the Head of Europe at Integra LifeSciences.
The document should demonstrate that I:
• have a realistic understanding of the Swiss MedTech market
• can clearly position the Codman Surgical portfolio
• correctly differentiate between capital equipment and consumables
• have a clear and pragmatic go to market approach for Switzerland
This is not marketing material, not a sales brochure, and not a presentation.
It is a strategic discussion document at executive level.
⸻
Expected Scope
• Target length: 1 to 2 pages executive pitch
• Optional extension: up to a maximum of 5 pages, only if it adds clear value
• The document must not feel overloaded
• Clarity, structure, and readability have priority over length
⸻
Deadline
Express delivery today
⸻
Target Audience
• Head of Europe, Integra LifeSciences
• European executive management
⸻
Delivery Format
Delivery is required as:
• PDF (final version)
• Editable file
• Word (.docx) or Google Docs
⸻
Layout and Style
• Very clean, high quality executive layout
• Calm consulting style
• Clear typography and generous white space
• Structured tables and concise sections
• No design gimmicks or marketing look
• Suitable to be printed and placed on the table during the meeting
Design should support the content, not dominate it.
⸻
Content Guidelines
1. Swiss Market Overview
• Switzerland as a small, highly structured market
• Relatively low annual procedure volumes
• High requirements for quality, evidence, and standardization
• Limited number of clearly defined neuro centers and reference hospitals
Short, factual, and precise.
⸻
2. Codman Surgical Portfolio Overview
Structured overview of the portfolio with clear separation:
Capital Equipment
• Typical products
• Clinical use
• Investment logic in Switzerland
• Typical decision makers
Consumables
• Typical products
• Clinical use
• Recurring consumption
• Purchasing and standardization logic
No marketing language. No superlatives.
⸻
3. Go to Market Approach Switzerland
• Different market approaches for:
• Capital equipment
• Consumables
• Role of:
• Reference hospitals
• Evaluations and pilot projects
• Clinical key opinion leaders
• Impact of low procedure volumes on prioritization and planning
⸻
4. Target Hospitals Switzerland
High level overview:
• University hospitals
• Large cantonal hospitals
• Selected private clinics
No need for a complete hospital list. Focus on logic and structure.
⸻
5. Optional: 90 Day Plan Switzerland
If useful, a concise and structured overview:
• Days 1 to 30: Market, portfolio, stakeholders
• Days 31 to 60: Clinical anchoring, references
• Days 61 to 90: Pilot projects, next steps
Maximum one page.
⸻
6. Closing Insight
Short, composed closing statement:
• Why Codman Surgical should be developed in Switzerland in a controlled and sustainable way
• Why a differentiated approach between capital equipment and consumables is critical
⸻
Tone
• Executive
• Clear
• Calm
• Confident
• No application language
• No sales jargon
⸻
Not Desired
• No marketing claims
• No SWOT analysis
• No assumptions about internal Integra numbers
• No overloaded charts or graphics
⸻
Expected Outcome
A document that makes a European executive think:
“This person understands the Swiss market and already thinks in terms of ownership and responsibility.”